Macular Disease: Clinical Trials

15 trials for Macular Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 6 unknown, 1 enrolling by invitation, 1 recruiting. 4 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Unknown 2
Phase 11Completed 1
Phase 21Completed 1
Phase 41Unknown 1

Follow Macular Disease: new trials by email Literature Review of Macular Disease trials Research Report on Macular Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standard Cut Rate 27-Gauge System Versus Ultrahigh-Speed 27-Gauge System in Macular Surgery
Ultrahigh-speed cut rate 27-gauge system, Standard cut rate 27-gauge system - Macular Disease
Not applicableUnknownSeoul National University Bundang Hospital662022-09-012022-08-15
High Resolution Optical Coherence Tomography
High-resolution optical coherence tomography (High-Res-OCT), Standard spectral domain OCT (SD-OCT) - Retinal Disease, Retinal Detachment
UnknownInsel Gruppe AG, University Hospital Bern5502021-11-302022-11-29
Implementation of the NEDS EyeCTester App
EyeCTester - Optic Nerve Disease, Macular Disease
Enrolling by invitationNeuro-Eye Diagnostic Systems, LLC1002019-01-092026-04-13
Polarization Perception in Health and Disease. Testing a New Sight Test
polarization sensitivity - Cataract, Age Related Macular Degeneration
UnknownSouth Warwickshire NHS Foundation Trust3002017-11-092019-01-30
Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery
FLACS +PPV+IOL + air, FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex, FLACS + PPV+IOL + internal limiting membrane peeling + air - Macular Disease, Rhegmatogenous Retinal Detachment
Not applicableUnknownAier School of Ophthalmology, Central South University1002017-01-012022-10-20
Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy
Vitrectomy - Macular Disease
CompletedKyorin University1002015-12-122019-02-20
Cohort Study of the Clinical Course of Macular Diseases in Kagawa
ranibizumab, aflibercept, pegaptanib, verteporphin - Macular Disease
Phase 4UnknownKagawa University10002014-12-012018-03-07
Cohort Study of the Clinical Course of Macular Diseases in Japanese
ranibizumab, aflibercept, pegaptanib, verteporphin - Macular Disease
UnknownKyoto University, Graduate School of Medicine10002014-03-012016-09-23
Translation of Eye Movement Reading Training to Clinical Practice
Platform for Administering Eye-movement Control Training - Macular Disease
Not applicableCompletedVA Office of Research and Development332014-01-012019-11-13
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
Macular Disease
TerminatedUniversity of Nebraska132013-12-202023-10-06
Epiretinal Proliferation in Eyes With Full Thickness Macular Hole
Vitrectomy - Macular Disease
CompletedKyorin University3902013-03-012017-12-18
CEI Van Outreach Screening Study
OCT imaging, the FDA Cleared iVue - Glaucoma, Macular Disease
CompletedOregon Health and Science University1182012-01-012018-04-12
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
Interferon gamma-1b - Retinal Disease, Macular Disease
Phase 1 / Phase 2CompletedNational Eye Institute (NEI)52011-10-012024-01-30
Clinicopathologic Findings for Macular Disease
vitrectomy for macular disease - Macular Disease
Not applicableCompletedHallym University Medical Center602009-05-012011-04-21
Novel Glaucoma Diagnostics
Glaucoma, Macular Disease
RecruitingWills Eye50002000-08-012024-08-15

Narrower conditions

Macular Degeneration (15)  ·  Retinal Diseases (4)  ·  Glaucoma (3)  ·  Cataract (2)  ·  Diabetic Retinopathy (2)  ·  Optic Nerve Diseases (2)  ·  Retinal Perforations (2)  ·  Central Serous Chorioretinopathy (1)  ·  Diabetes Mellitus (1)  ·  Epiretinal Membrane (1)  ·  Hypertensive Retinopathy (1)  ·  Keratoconus (1)  ·  Macular Edema (1)  ·  Papilledema (1)  ·  Pseudophakia (1)

Broader conditions

Eye Diseases (15)  ·  Retinal Degeneration (15)  ·  Retinal Diseases (11)  ·  Endocrine System Diseases (3)  ·  Ocular Hypertension (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Cardiovascular Diseases (2)  ·  Cranial Nerve Diseases (2)  ·  Diabetes Complications (2)  ·  Diabetes Mellitus (2)  ·  Diabetic Angiopathies (2)  ·  Lens Diseases (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Vascular Diseases (2)

Interventions

Vitrectomy (3)  ·  Ranibizumab (2)  ·  Verteporfin (2)  ·  aflibercept (2)  ·  pegaptanib (2)  ·  Air (1)  ·  Calcium Dobesilate (1)  ·  interferon gamma-1b (1)

Sponsors

Kyorin University (2)  ·  Aier School of Ophthalmology, Central South University (1)  ·  Hallym University Medical Center (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Kagawa University (1)  ·  Kyoto University, Graduate School of Medicine (1)  ·  National Eye Institute (NEI) (1)  ·  Neuro-Eye Diagnostic Systems, LLC (1)  ·  Oregon Health and Science University (1)  ·  Seoul National University Bundang Hospital (1)  ·  South Warwickshire NHS Foundation Trust (1)  ·  University of Nebraska (1)  ·  VA Office of Research and Development (1)  ·  Wills Eye (1)

Countries

United States (6)  ·  Japan (4)  ·  South Korea (2)  ·  China (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Makoto Inoue, MD (2)  ·  Akiataka Tsujikawa, MD (1)  ·  Emily Y Chew, M.D. (1)  ·  Janet P Szlyk, PhD (1)  ·  Joel S Schumann, MD (1)  ·  Kyu Hyung Park, M.D., Ph.D. (1)  ·  Michael Chiang, MD (1)  ·  Nagahisa Yoshimura, MD (1)  ·  Oussama Habra, MD (1)  ·  Rosa A Tang, MD (1)  ·  Vikas Gulati, MD (1)  ·  Wensheng Li (1)

Results publications

PMID 18385097, PMID 18515577, PMID 18657796, PMID 18779718, PMID 19387076, PMID 20662848, PMID 21296824, PMID 22234714, PMID 22879425, PMID 26291073, PMID 29185499, PMID 42518077

NIH funding

R01EY013178 (1)